Results 181 to 190 of about 10,304 (198)

Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development

Trends in Pharmacological Sciences, 2023
Graciela Andrei, Robert Snoeck
exaly  

Mpox Outbreak Update

JAMA, 2023
openaire   +2 more sources

Mpox: epidemiology, clinical manifestations and recent developments in treatment and prevention

Expert Review of Anti-Infective Therapy, 2023
exaly  

Du Mpox endémique au Mpox pandémique

La Revue de Médecine Interne
Alexandre Robin, Yasmine Abi Aad, Nadia Valin, Romuald Cruchet, Pauline Naudion, Thibault Chiarabini, Quentin Richier   +6 more
openaire   +1 more source

Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018–2024: Predominance of zoonotic transmission

Cell
Adrienne Amuri-Aziza, Akil-Bandali, Noella Mulopo-Mukanya   +2 more
exaly  

Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates

Cell
Patricia L Earl, Daniel Stadlbauer, Jeffrey L Americo   +2 more
exaly  

Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic

Cell
MIGUEL I Paredes, Marlin Figgins, Vittoria Colizza   +2 more
exaly  

Vaccination to prevent mpox

BMJ
Nick, Andrews, Sema, Mandal
openaire   +2 more sources

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination

JAMA - Journal of the American Medical Association
Katherine Mcmahan, Catherine Jacob-Dolan, Jinyan Liu   +2 more
exaly  

Early Tecovirimat Treatment for Mpox Disease Among People With HIV

JAMA Internal Medicine
Amalia Aldredge, Sheetal Kandiah, Valeria D Cantos   +2 more
exaly